Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail

Journal of the American Academy of Dermatology

Volumn 38, Issue 6 II, 1998, Pages

  Ling, M R ^a   Swinyer, L J ^a   Jarrat, M T ^a   Falo, L ^a   Monroe, E W ^a   Tharp, M ^a   Kalivas, J ^a   Weinstein, G D ^a   Asarch, R G ^a   Drake, L ^a   Martin, A G ^a   Leyden, J J ^a   Cook, J ^a   Pariser, D M ^a   Pariser, R ^a   Thiers, B H ^a   Lebwohl, M G ^a   Babel, D ^a   Stewart, D M ^a   Eaglstein, W H ^a   Falanga, V ^a   Katz, H I ^a   Bergfeld, W F ^a   Hanifin, J M ^a   Kang, S ^a   McDonald, C J ^a   Muglia, J ^a   Goffe, B S ^a   Young, M R ^a   more..

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; TERBINAFINE;

ARTHRALGIA; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAIL DISEASE; ONYCHOMYCOSIS; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; TOPICAL DRUG ADMINISTRATION; TREATMENT FAILURE; TREATMENT OUTCOME; TRICHOPHYTON RUBRUM;

EID: 17544402718     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0190-9622(98)70492-x     Document Type: Review

References (13)

1. J André G. Achten Onchomycosis Int J Dermatol 26 1987 481 490
2. V Ramesh BSN Reddy R Singh Onychomycosis Int J Dermatol 22 1983 148 152
3. G Midgley MK Moore JC Cook QG Phan Mycology of nail disorders J Am Acad Dermatol 31 1994 S68 S74
4. RJ Hay Onychomycosis: agents of choice Dermatol Clin 11 1993 161 169
5. AK Gupta DN Sauder NH Shear Antifungal agents: an overview. Part II J Am Acad Dermatol 30 1994 911 933
6. R Arenas G Fernández L. Domínguez Onychomycosis treated with itraconazole or griseofulvin alone with or without a topical antimycotic or keratolytic agent Pharmacol Ther 30 1991 586 589
7. T Piepponen K Blomqvist H Brandt V Havu A Hollmen K Kohtamäki Efficacy and safety of itraconazole in the long-term treatment of onychomycosis J Antimicrob Chemother 29 1992 195 205
8. GT Nahass M Sisto Onychomycosis: successful treatment with once-weekly fluconazole Dermatology 186 1993 59 61
9. F Montero-Gei M Robles-Soto A Leon Fluconazole in the treatment of onychomycosis Int J Dermatol 35 1996 587 588
10. JE Fräki HT Heikkilä MO Kero K Kuokkanen R Oksman T Rantanen A noncomparative study of the efficacy and safety of fluconazole in the treatment of onychomycosis Eur J Clin Microbiol Infect Dis November 1996 Submitted to
11. RJ Hay Risk/benefit ratio of modern antifungal therapy: focus on hepatic reactions J Am Acad Dermatol 29 1993 S50 S54
12. KW Brammer PR Farrow JK Faulkner Pharmaco-kinetics and tissue penetration of fluconazole in humans Rev Infect Dis 12 suppl 3 1990 S318 S326
13. RJ Hay Pharmacokinetic evaluation of fluconazole in skin and nails Int J Dermatol 31 suppl 2 1992 6 7